Viome Dx

Viome Life Sciences Unveils CancerDetect™, the Future of Oral and Throat Cancer Detection

CancerDetect™ brings unprecedented accuracy to early cancer detection and prevention as the only oral and throat cancer test to offer detection with 95% specificity and 90% sensitivity. Oral and throat cancer is notoriously difficult to detect.

Until now, it can often go undiagnosed until it has reached an advanced stage due to a lack of effective diagnostics tools, leading to low survival rates. Only 28% of patients receive an early diagnosis, and those receiving a late diagnosis face a prolonged battle with oral cancer. (National Library of Medicine).

Early detection directly increases the 5-year survival rate for oral cancer patients, from 50% to 84%. With CancerDetect™, Viome has developed a much-needed aid to detect early-stage cancer, leading to more successful treatment outcomes when confirmed with a biopsy.

***Disclaimer***
Viome's CancerDetect Test is not an FDA-approved or cleared test.

Naveen Jain, Founder of Viome Life Sciences, debuts as Neurohacker Collective guest host, along with Viome Life Scieces' Global Head of R&D, Dr. Emmanuel Hanon, taking us on a thrilling discussion of how gut microbiome research is shaping the future of disease prevention and longevity. We dive deep into the bilateral connection between the gut and the brain, unpacking:

-The role of the gut-brain axis and gene expression in disease prevention
-How the gut microbiome informs the immune system
-The fascinating relationship between the microbiome, neuromodulation, and mood

"There is a bilateral connection between your gut and your brain and the information circulates through the parasympathetic, sympathetic nerve, and vagus nerve." - Emmanuel Hanon, Ph.D.

Gut-Brain Connection - Dr. Emmanuel Hanon - Cognition We have a Collective Insights first for you! Today Naveen Jain, Founder of Viome, debuts as our guest host, along with fellow colleague Dr. Hanon, taking us on a thrilling discussion of how gut microbiome research is shaping the future of disease prevention and longevity. We dive deep into the bilat...

Are you a life science researcher interested in a GRANT for state-of-the-art molecular data analysis? Viome Life Sciences has opened up our ViOS platform, and is offering grants to help translate research into clinical applications, devising new therapies and developing more effective diagnostics and companion diagnostics.

Learn more about our Grants Program and apply here:

Viome Life Sciences - Grants Viome's science arm, Viome Life Sciences, focuses on developing consumer-friendly tests, offering research grants and collaborating with world class scientists and clinicians.

Meet Dr. Emmanuel Hanon, our Global Head of Research & Development!

As global head of R&D for the vaccine group at GSK, Dr. Hanon oversaw teams across 50 countries dedicated to delivering discovery, development, and management activities for the company's vaccine efforts. Dr. Hanon was responsible for the shared science and technology platforms supporting the entire vaccine business, managing technical development, clinical immunology, and preclinical stages of vaccine developments.

We are so lucky to have him with us. Say hello! https://buff.ly/3IJK0Ne